Let My Doctors Decide Action Network – Trademark Portfolio

Entity Type: 54

Let My Doctors Decide Action Network holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include LET MY DOCTORS DECIDE and LET MY DOCTORS DECIDE ACTION NETWORK. The owner is based in Washington, DC.

2021 L ST NW STE 101-179

Washington, DC 20036

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Let My Doctors Decide Action Network's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Let My Doctors Decide Action Network have?

Let My Doctors Decide Action Network has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Let My Doctors Decide Action Network file in?

Let My Doctors Decide Action Network files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.

What are Let My Doctors Decide Action Network's most well-known trademarks?

Let My Doctors Decide Action Network's registered trademark portfolio includes well-known marks such as LET MY DOCTORS DECIDE and LET MY DOCTORS DECIDE ACTION NETWORK. These are among 2 currently registered trademarks in the portfolio.

What is Let My Doctors Decide Action Network's trademark registration success rate?

Let My Doctors Decide Action Network has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.